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Aim. Cancer of the oral cavity is the eighth most common malignancy in the world. The disease is 
diagnosed after a considerable delay and predict the individual progression is difficult. The 
improvements of the therapy did not increased the rate of survival at 5 years, that is still about 50%. The 
identification of the possible markers that indicates the progression of the tumor is therefore necessary. 
Endocannabinoids may play an important role in the process of carcinogenesis in the oral mucosa. They 
are able to bind and activate specific membrane receptors coupled to G proteins, cannabinoid 
receptors CB1 and CB2. The purpose of this study is to evaluate the expression of CB1 and CB2 receptors 
in the development of oral cancer through the immunohistochemical study on samples of OSCC. 
Materials and methods. We selected 44 cases of patients with the primary tumor in the oral cavity. The 
stage of the tumor was classified according to the TNM system. The tumors grading was divided into I, II 
and III grade. The paraffin sections were analyzed by immunohistochemistry. The assessment of the 
immunoreactivity for CB1 and CB2 receptors was weak or strong. For quantitative analysis the expression 
of CB1 and CB2 receptors was evaluated in percentage with scale of values ??ranging from 0 to 100%. 
Results. The immunohistochemical examination of the samples analyzed showed the absence of 
expression of CB1 and CB2 receptors in normal mucosa, while peritumoral mucosa showed a weak 
expression in the vicinity of cancer and tumor mucosa showed an overexpression of receptors. 
Furthermore, the intensity of staining increased with the increase of the grading. It can be concluded 
that the strong immunoreactivity of CB1 and CB2 receptors is related to aggressive behavior of oral 
carcinoma. 
Conclusions. The analysis of endocannabinoids and their receptors on tissue biopsies taken from 
carcinoma of the oral cavity may therefore indicate future therapeutic targets and new prognostic 
biomarkers in these patients, especially in the early stages of the disease. The ultimate goal of this work is 
to indicate the possible role of CB1 and CB2 receptors such as tumor biomarker that may help in the 
early diagnosis of oral cancer and therefore contribute to reduce drastically the mortality of this disease. 
